Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

SGXC:9G2 Revenue

Singapore Institute of Advanced Medicine Holdings had revenue of 8.26M SGD in the half year ending December 31, 2025, a decrease of -3.35%. This brings the company's revenue in the last twelve months to 15.57M, down -2.22% year-over-year. In the fiscal year ending June 30, 2025, Singapore Institute of Advanced Medicine Holdings had annual revenue of 15.71M, down -5.63%.

• Revenue (ttm): 15.57M
• Revenue Growth: -2.22%
• P/S Ratio: 3.32
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 51.72M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	15.71M	-936.78K	-5.63%
Jun 30, 2024	16.65M	412.41K	2.54%
Jun 30, 2023	16.23M	2.43M	17.56%
Jun 30, 2022	13.81M	891.35K	6.90%
Jun 30, 2021	12.92M	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 22, 2026

Data Sources Report a data error